Journal article

CXCL-10, interleukin-12 and interleukin-21 are not immunological predictors of HBeAg seroconversion in HIV-1-HBV coinfection following HBV-active antiretroviral therapy

Paola Giarda, Anchalee Avihingsanon, Joe Sasadeusz, Jennifer Audsley, Pip Marks, Gail Matthews, Kiat Ruxrungtham, Sharon R Lewin, Megan Crane

ANTIVIRAL THERAPY | INT MEDICAL PRESS LTD | Published : 2014

DOI: 10.3851/IMP2720

Related Projects (1)

Project icon

HIV-HBV CO-INFECTION

Morbidity and mortality secondary to liver disease is greatly increased in people co-infected with HIV and HBV compared to those infected wi..

Grants

Awarded by NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES

Awarded by NIAID NIH HHS

Citation metrics

1Web of Science
1Scopus
2Dimensions

Keywords

Virology
Adult
Liver-Related Mortality
Interleukins
Progression
Serum-Levels
Humans
Interleukin-12
Pharmacology & Pharmacy
Science & Technology
Coinfection
Life Sciences & Biomedicine
Antiretroviral Therapy, Highly Active
Female
Hepatitis B E Antigens
Hepatitis-B-Virus
Cohort
Treatment Outcome
Infected Patients
Chemokine Cxcl10
Male
Infectious Diseases
Hiv Infections
Cd4 Lymphocyte Count
Hepatitis B
Viral Load